NAHB Housing Market Index Drops To 42; SP500 Tests Session Lows
Concerns over tariffs and mortgage rates put pressure on builder sentiment in February.
Bears Suddenly at Risk as S&P 500 Support Steps Up
Last week, investors absorbed more headlines on tariffs, plus Fed Chairman Jerome Powell's testimony to Congress, inflation data, and the release of the January consumer price index (CPI) and producer price index (PPI) reports.
The S&P 500's race to a new record may tip it into a bigger pullback. Here's why.
S&P 500 looks poised to break out from the top of its multi-week trading range.
S&P 500 rally isn't sustainable, veteran trader warns
Wall Street veteran warns that markets are ‘over their skis.' Transcript: CONWAY GITTENS: So can you describe the market environment that we are in right now, and how does it compare to Trump 1.0?
S&P 500 pulls back after rally, eyes fresh all-time high
8:45am: Futures take a breather as retail sales disappoint US stock futures dipped on Friday morning as investors digested a busy week of inflation data, tariff updates, and corporate earnings, with fresh retail sales figures adding to the market's cautious tone. Dow Jones futures declined 0.3%, while S&P 500 futures were down 0.2%.
S&P 500 could still see double-digit gains despite higher yields: Strategist
Paul Christopher of Wells Fargo Investment Institute discusses his investment strategy within the current economic environment, and explains why he thinks U.S. equities could still get a boost this year despite elevated Treasury yields.
S&P 500 Rises 1% as Dollar Falls | Closing Bell
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Alix Steel, Scarlet Fu, Carol Massar and Tim Stenovec. -------- More on Bloomberg Television and Markets Like this video?
The S&P 500 pushed through its trading range — but can the bulls hold the line?
The stock market's internal indicators are mixed.
West Pharma's stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin
West Pharmaceutical Services Inc.'s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 that was well below expectations.
This Pharma Stock Is Today's Worst in the S&P 500. Here's Why.
West Pharmaceutical Services fails to impress with a weak 2025 outlook.
This Railroad-Equipment Maker's Stock Is the S&P 500's Worst Performer. Blame Earnings.
Shares of Wabtec are on track for their largest daily percentage decrease in nearly five years.
S&P 500 futures hold steady as market braces for inflation report and Fed signals
US stock futures remained largely unchanged on Tuesday evening, as investors awaited the release of January's critical inflation report. The report's findings are expected to offer crucial insights into the Federal Reserve's interest rate plans, against a backdrop of fast-moving economic policies under President Donald Trump.
